Trials / Terminated
TerminatedNCT05804708
Phase 2 Clinical Trial of GH001 in Postpartum Depression
A Phase 2 Clinical Trial of GH001 in Patients with Postpartum Depression
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- GH Research Ireland Limited · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, open-label, single-arm Phase 2 clinical trial. Approximately 15 female participants with clinically diagnosed postpartum depression (PPD) will be included in this study. The participants will receive an individualized dosing regimen (IDR) with at least one and up to three doses of GH001 administered within a single day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GH001 | GH001 is administered via inhalation |
Timeline
- Start date
- 2023-03-02
- Primary completion
- 2024-08-02
- Completion
- 2024-11-15
- First posted
- 2023-04-07
- Last updated
- 2025-02-18
Locations
4 sites across 2 countries: Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT05804708. Inclusion in this directory is not an endorsement.